These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

261 related items for PubMed ID: 21748312

  • 1. Different serum anti-Müllerian hormone concentrations are associated with oocyte quality, embryo development parameters and IVF-ICSI outcomes.
    Irez T, Ocal P, Guralp O, Cetin M, Aydogan B, Sahmay S.
    Arch Gynecol Obstet; 2011 Nov; 284(5):1295-301. PubMed ID: 21748312
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. The use of anti-Müllerian hormone and antral follicle count to predict the potential of oocytes and embryos.
    Majumder K, Gelbaya TA, Laing I, Nardo LG.
    Eur J Obstet Gynecol Reprod Biol; 2010 Jun; 150(2):166-70. PubMed ID: 20223579
    [Abstract] [Full Text] [Related]

  • 5. Anti-Müllerian hormone: correlation of early follicular, ovulatory and midluteal levels with ovarian response and cycle outcome in intracytoplasmic sperm injection patients.
    Elgindy EA, El-Haieg DO, El-Sebaey A.
    Fertil Steril; 2008 Jun; 89(6):1670-6. PubMed ID: 17658520
    [Abstract] [Full Text] [Related]

  • 6. Serum antimüllerian hormone/müllerian-inhibiting substance appears to be a more discriminatory marker of assisted reproductive technology outcome than follicle-stimulating hormone, inhibin B, or estradiol.
    Hazout A, Bouchard P, Seifer DB, Aussage P, Junca AM, Cohen-Bacrie P.
    Fertil Steril; 2004 Nov; 82(5):1323-9. PubMed ID: 15533354
    [Abstract] [Full Text] [Related]

  • 7. AMH has no role in predicting oocyte quality in women with advanced age undergoing IVF/ICSI cycles.
    Dai X, Wang Y, Yang H, Gao T, Yu C, Cao F, Xia X, Wu J, Zhou X, Chen L.
    Sci Rep; 2020 Nov 12; 10(1):19750. PubMed ID: 33184364
    [Abstract] [Full Text] [Related]

  • 8. Follicular fluid levels of anti-Mullerian hormone as a predictor of oocyte maturation, fertilization rate, and embryonic development in patients with polycystic ovary syndrome.
    Mashiach R, Amit A, Hasson J, Amzalzg S, Almog B, Ben-Yosef D, Lessing JB, Limor R, Azem F.
    Fertil Steril; 2010 May 01; 93(7):2299-302. PubMed ID: 19261276
    [Abstract] [Full Text] [Related]

  • 9. Basal level of anti-Müllerian hormone is associated with oocyte quality in stimulated cycles.
    Ebner T, Sommergruber M, Moser M, Shebl O, Schreier-Lechner E, Tews G.
    Hum Reprod; 2006 Aug 01; 21(8):2022-6. PubMed ID: 16679324
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Using anti-Müllerian hormone to identify a good prognosis group in women of advanced reproductive age.
    Fridén B, Sjöblom P, Menezes J.
    Aust N Z J Obstet Gynaecol; 2011 Oct 01; 51(5):411-5. PubMed ID: 21988118
    [Abstract] [Full Text] [Related]

  • 12. Inhibin B and anti-Mullerian hormone: markers of ovarian response in IVF/ICSI patients?
    Muttukrishna S, Suharjono H, McGarrigle H, Sathanandan M.
    BJOG; 2004 Nov 01; 111(11):1248-53. PubMed ID: 15521870
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Estradiol supplementation during the luteal phase of IVF-ICSI patients: a randomized, controlled trial.
    Serna J, Cholquevilque JL, Cela V, Martínez-Salazar J, Requena A, Garcia-Velasco JA.
    Fertil Steril; 2008 Dec 01; 90(6):2190-5. PubMed ID: 18191847
    [Abstract] [Full Text] [Related]

  • 20. [Value of serum inhibin B measurement in predicting ovarian response in controlled ovarian hyperstimulation for in vitro fertilization cycle].
    Chen Y, Yu Q, Zhang YW, He FF, Sun ZY.
    Zhonghua Fu Chan Ke Za Zhi; 2006 Jun 01; 41(6):368-71. PubMed ID: 16831355
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.